No profile data available.
Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS) is a healthcare company in the drug manufacturing contractors industry, based in Indore, India, with about 24 full-time employees.
It reported revenue of 334.02 million INR for fiscal year 2025, down 16.6% from fiscal year 2024, and net income of 5.58 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 8.56 million INR, down 94.0% from a year before. Its largest business segment, Pharma Division, brought in 80% of segment revenue in fiscal year 2025. Its market capitalization was 490.66 million INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
Biofil Chemicals and Pharmaceuticals Limited engages in the manufacturing and trading of pharmaceutical products in India. It operates through Pharma and Chemical segments.
Biofil Chemicals and Pharmaceuticals reported 334.02 million INR in revenue for fiscal year 2025, down 16.6% from 400.35 million INR in fiscal year 2024. In Q3 2026 revenue was 8.56 million INR.
Pharma Division, with 266.60 million INR or 80% of segment revenue in fiscal year 2025. Next: Chemical Division (20%).
490.66 million INR as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Panchsheel Organics Limited (PANCHSHEEL.BO), Tyche Industries Limited (TYCHE.BO), Sunil Healthcare Limited (SUNLOC.BO), ANG Lifesciences India Limited (ANG.BO).